26.4 C
Lagos

WHO Advises Against The Use Of Remdsivir To Treat Covid-19

Must Read

FG, Organised Labour Rescheduled Meeting Underway In Abuja

The rescheduled meeting between the federal government and organised labour is underway in Abuja.

Nigerian Coach Releases Final 20-Man Squad For WAFU Cup [Full list]

Isa Ladan Bosso,Nigeria’s Flying Eagles coach, has named his final 20-man squad that will contest for the...

India Slips Into Recession, Worst Among Major Economies

India’s economy contracted 7.5 percent between July and September, performing the poorest among major advanced and emerging...

The anti-viral drug Remdesivir should not be used to treat Covid-19 patients no matter how severe their illness as it has “no important effect” on survival chances, the World Health Organization said Friday.

Scratching one of the few treatments that had shown some initial promise in severe patients, a WHO Guideline Development Group (GDG) of international experts said there was “no evidence based on currently available data that it does improve patient-important outcomes”.

The United States, the European Union and other countries have granted temporary approval for the use of Remdesivir after initial research showed it may shorten recovery time in some coronavirus patients.

President Donald Trump was treated with Remdesivir among other medicines after he tested positive for Covid-19 in October.

Friday’s WHO recommendation was based on four international randomised trials among more than 7,000 patients hospitalised with the virus.

Publishing updated treatment guidance in the BMJ medical journal, the panel acknowledged that their recommendation does not mean that Remdesivir has no benefit for patients.

[READ ALSO] Joe Biden Celebrates His 78th Birthday

But based on the latest figures, costs and delivery methods, it advised “against administering Remdesivir in addition to usual care for the treatment of patients hospitalised with Covid-19, regardless of disease severity”.

Manufacturer Gilead said last month that the drug had boosted 2020 third quarter sales by almost $900 million.

Initially developed as a treatment for the Ebola virus, Remdesivir was found in one study published in May to reduce the length of hospital stays for Covid-19 sufferers from 15 to 11 days on average.

A subsequent WHO pre-print however found the drug “appeared to have little or no effect” on mortality or length of hospitalisation among more than 11,000 hospitalised patients across 30 countries.

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

FG, Organised Labour Rescheduled Meeting Underway In Abuja

The rescheduled meeting between the federal government and organised labour is underway in Abuja.

Nigerian Coach Releases Final 20-Man Squad For WAFU Cup [Full list]

Isa Ladan Bosso,Nigeria’s Flying Eagles coach, has named his final 20-man squad that will contest for the WAFU Cup of nations tournament.

India Slips Into Recession, Worst Among Major Economies

India’s economy contracted 7.5 percent between July and September, performing the poorest among major advanced and emerging economies and entering a technical...

Nigerian lawmaker, Victor Mela Sentenced To Prison

A member of the House Representatives, Victor Mela, has been sentenced to one month imprisonment. A Magistrate Court in...

No Pardon For Gender Violence Offenders, Rapists, Says Sanwo-Olu

Governor of Lagos State, Babajide Sanwo-Olu has insisted that there is no pardon for such people in Nigeria’s commercial nerve centre.
- Advertisement -

More Articles Like This

- Advertisement -